Clinical Trial Update: Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular Carcinoma

View source ↗

Summary

This clinical trial update reports on real-life use of atezolizumab-bevacizumab and other immunotherapies for hepatocellular carcinoma; the study is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Hepatocellular Carcinoma (HCC) | Status: RECRUITING